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In a study published in this issue of Critical Care, Gogos 
and colleagues [1] investigated the inﬂ  uence of the type 
of bacterial infection, the compartment where it occurs, 
its origin (community or nosocomial), and its severity 
(sepsis versus severe sepsis or septic shock) on lympho-
penia, on the respective number of mononuclear cell 
sub  sets, on apoptosis of circulating mononuclear cells, 
and on HLA-DR expression on monocytes. Th  e same 
group had already reported that tumor necrosis factor 
(TNF) and interleukin (IL)-6 production by lipopoly  sac-
charide (LPS)-stimulated monocytes was lower in sepsis 
patients with ventilator-associated pneumonia than in 
patients with sepsis due to other types of infections [2]. 
Th  ese analyses permit clinicians to monitor sepsis 
patients’ immune status, which undergoes numerous 
modiﬁ   cations gathered under the term ‘compensatory 
anti-inﬂ  ammatory response syndrome’ [3].
Lymphopenia is a hallmark of sepsis. It aﬀ  ects most 
lymphocyte subsets, although some divergent observa-
tions for B lymphocytes exist [4-6]. Importantly, lympho-
penia is accompanied by modiﬁ  cations of the CD4+/CD8+
ratio and the relative percentage of cellular subsets. For 
example, among lymphocytes, the percentages of Treg 
(regulatory T) [7] and of natural killer (NK) [8] cells are 
enhanced. Lymphopenia already has been associated 
with bacteremia [9], has been found to be more severe in 
patients with Gram-positive infection than in those with 
Gram-negative infection [4], and has been found to 
inversely correlate with outcome [10]. It can be mimicked 
by injections of live bacteria, LPS, IL-1, or TNF in animal 
models. Th  e mechanisms that lead to lymphopenia are 
mainly a redistribution of activated cells that leave the 
blood compartment to migrate toward the tissues, 
particularly toward lymphatic tissues, and the occurrence 
of apoptosis. Apoptosis of lymphocytes during human 
sepsis was revealed by the Hotchkiss group [11] when 
studying the spleens of patients who died of sepsis. Le 
Tulzo and colleagues [12] showed that apoptosis of 
circulating lymphocytes was signiﬁ   cantly lower in 
patients with sepsis than in those with septic shock. 
Hotchkiss and colleagues [13] showed that apoptosis was 
aﬀ  ecting circulating NK cells, B lymphocytes, and CD4+
and CD8+ T lymphocytes. Th   e reduced HLA-DR expres-
sion on CD14+ monocytes is another hallmark of sepsis 
and systemic inﬂ  ammatory response syndrome. It is a 
useful prognosis marker of intensive care patients and 
correlates with the occurrence of sepsis [14]. Measure-
ments performed a few days after the onset of sepsis 
appear as a prognosis marker, and low expression corre-
lates with poor outcome [15]. IL-10 and glucocorticoids 
are the main mediators that lower HLA-DR expression, 
although they act diﬀ  erently on CD14HIGHCD16NEG and 
CD14LOWCD16POS monocyte subsets [16].
Th  e present study illustrates the importance of being 
careful when comparing diﬀ  erent reports, which often 
include diﬀ   erent types of patients with sepsis. Th  e 
hetero  geneity of the patients gathered under the term 
‘sepsis’ is a nightmare for anyone who wishes to submit 
grant applications or articles, since reviewers can easily 
argue that the studied group is ill deﬁ  ned and too hetero-
geneous! Th  is study further emphasizes the diﬃ   culty of 
reaching deﬁ   nite conclusions on patients with sepsis 
when considered as a global group. Th  e conclusions 
drawn for sepsis patients with pyelonephritis may not be 
true for sepsis patients with community-acquired 
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Studying a large number of patients with sepsis, 
the Hellenic sepsis study group led by Evangello 
Giamarellos-Bourboulis emphasizes that the nature 
of the bacterial infection, its origin (community or 
nosocomial), its site, and its severity exert diff  erent 
pressures on the immune system. Their study illustrates 
the heterogeneity of patients with sepsis and points 
out that numerous key parameters of severe infection 
infl  uence immune status.
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© 2010 BioMed Central Ltdpneu  monia or intra-abdominal infection. However, 
although the authors report diﬀ  erences, these diﬀ  erences 
were minimal. Only community-acquired pneumonia 
was associated with a higher number of NK cells as 
compared with the other groups, and only intra-
abdominal infec  tion was associated with an enhanced 
number of CD8+ cells. Th   e latter group was the only one 
with a signiﬁ    cantly enhanced number of apoptotic CD8+ 
cells. Reduced expression of HLA-DR on CD14+ cells was 
seen mainly in patients infected with Klebsiella 
pneumoniae or Acinetobacter baumanii. Surprisingly, 
when patients with sepsis were compared with those with 
severe sepsis and septic shock, the number of signiﬁ  cant 
diﬀ   erences in terms of the number of circulating NK 
cells, CD4+ T lymphocytes, CD8+ T lymphocytes, and B 
lymphocytes was limited to community-acquired pneu-
monia and intra-abdominal infection. Such a diﬀ  erence 
was not seen in patients with nosocomial pneumonia, 
pyelonephritis, or bacteremia. Enhanced apoptosis of NK 
and NKT cells was seen mainly in severe sepsis or septic 
shock caused by nosocomial pneumonia. Finally, HLA-
DR expression was particularly reduced in patients with 
severe sepsis or septic shock due to pyelonephritis or 
intra-abdominal infection. Altogether, it is heartening to 
note that there were fewer diﬀ   erences than similarities 
between the diﬀ   erent sepsis subgroups. Who else but 
Hippocrates can oﬀ  er us a conclusion for this study from 
Greece: ‘It is more important to know what sort of person 
has a disease than to know what sort of disease a person has’.
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